Ecovia Bio Closes Series B Funding Round Led by Pointe Angels to Expand Manufacturing Capacity

Ecovia Bio完成由Pointe Angels领投的B轮融资，以扩大生产产能。

GROSSE POINTE, Mich., February 3, 2026-- Ecovia Bio, an advanced biotechnology company specializing in sustainable, high-performance biopolymer ingredients, today announced the closing of a Series B funding round led by Pointe Angels, an independent angel investor group based in the Grosse Pointe communities east of Detroit, Michigan.

密歇根州格罗斯波因特，2026年2月3日——Ecovia Bio是一家专注于可持续高性能生物聚合物成分的先进生物技术公司，今天宣布完成了由密歇根州底特律东部格罗斯波因特社区的独立天使投资团体Pointe Angels领投的B轮融资。

The funding will support significant expansion of manufacturing capacity at Ecovia Bio's state-of-the-art Livonia facility to meet surging global demand for its AzuraBase and AzuraGel families of gamma polyglutamic acid (γ-PGA) and specialty biopolymer products across cosmetics, personal care, agriculture, and hygiene applications..

这笔资金将支持Ecovia Bio公司最先进的利沃尼亚工厂大幅扩展制造能力，以满足全球对其AzuraBase和AzuraGel系列γ-聚谷氨酸（γ-PGA）及特种生物聚合物产品在化妆品、个人护理、农业和卫生应用领域激增的需求。

Addressing a Global Environmental and Health Imperative

应对全球环境与健康迫切需求

Microplastics have emerged as one of the most pressing environmental and public health challenges of our time. Superabsorbent polymers (SAPs)---synthetic, petrochemical-derived plastics used extensively in diapers, feminine hygiene products, cosmetics, lotions, and other consumer goods---persist in landfills for centuries and fragment into harmful microplastics that contaminate soil, water systems, and the food chain.

微塑料已经成为我们这个时代最紧迫的环境和公共卫生挑战之一。超级吸水性聚合物（SAPs）——广泛用于尿布、女性卫生用品、化妆品、乳液和其他消费品中的合成石化衍生塑料——在垃圾填埋场中可存留数百年，并分解成有害的微塑料，污染土壤、水系统和食物链。

These microplastics have been detected in human blood, lungs, and placental tissue, raising serious health concerns. Ecovia Bio's biodegradable γ-PGA technology represents a transformative solution, enabling manufacturers to replace these persistent synthetic polymers with a bio-based, fully biodegradable alternative that delivers equivalent or superior performance without environmental or health consequences.

这些微塑料已在人类血液、肺部和胎盘组织中被检测到，引发了严重的健康担忧。Ecovia Bio的可生物降解γ-PGA技术代表了一种变革性的解决方案，使制造商能够用一种基于生物、完全可生物降解的替代品取代这些持久性合成聚合物，在不带来环境或健康后果的情况下提供相同或更优的性能。

By scaling production of γ-PGA, Ecovia Bio is empowering a global shift toward truly sustainable consumer products---addressing regulatory pressures, consumer demand for safer products, and the urgent need to protect human health and environmental integrity..

通过扩大γ-PGA的生产，Ecovia Bio正在推动全球向真正可持续的消费品转变——应对监管压力、消费者对更安全产品的需求，以及保护人类健康和环境完整性的迫切需要。

Ecovia Bio's products are designed to reduce dependence on petrochemicals while delivering superior performance in demanding applications. By expanding manufacturing capacity and establishing the roadmap for additional production sites, Ecovia Bio is positioning itself to become the trusted global supplier of choice for γ-PGA and related biopolymers across consumer and industrial markets..

Ecovia Bio的产品旨在减少对石化产品的依赖，同时在苛刻的应用中提供卓越的性能。通过扩大生产能力并制定额外生产站点的路线图，Ecovia Bio正将自己定位为消费者和工业市场中γ-PGA及相关生物聚合物的全球首选可靠供应商。

About the Funding

关于资金

The Series B round will fuel a comprehensive expansion program that increases production capacity across Ecovia Bio's Livonia manufacturing facility. With this investment, the company projects the facility will achieve full operational capacity by 2028, positioning Ecovia Bio to serve growing customer demand across multiple high-growth markets.

B轮融资将推动一项全面的扩张计划，提升Ecovia Bio位于利沃尼亚制造工厂的生产能力。通过此次投资，公司预计该工厂将在2028年实现满负荷运营，使Ecovia Bio能够满足多个高增长市场中不断增长的客户需求。

Notably, the company has already begun evaluation of additional production facilities to accommodate market demand beyond 2028 and secure long-term supply chain security for global partners..

值得注意的是，该公司已经开始评估额外的生产设施，以满足2028年以后的市场需求，并确保全球合作伙伴的长期供应链安全。

'We are excited to partner with Pointe Angels,' said Kousay Said, CEO of Ecovia Bio. 'This capital enables us to meet immediate demand from our cosmetics, personal care, and agricultural customers while establishing the infrastructure needed to serve the hygiene sector at industrial scale.'

“我们很高兴与Pointe Angels合作，”Ecovia Bio首席执行官Kousay Said表示。“这笔资金使我们能够满足化妆品、个人护理和农业客户当前的需求，同时建立为卫生领域大规模服务所需的基础设施。”

'Ecovia Bio represents exactly the kind of venture we love to back at Pointe Angels,' said David Bloom, Executive Director of Pointe Angels. 'The company has solved a real technical challenge---producing sustainable, high-performance γ-PGA at commercial scale---and now has the market traction to justify expansion.

“Ecovia Bio正是我们Pointe Angels喜欢支持的那种企业，”Pointe Angels执行董事大卫·布鲁姆表示。“该公司解决了真正的技术难题——大规模生产可持续、高性能的γ-PGA——现在已获得市场认可，为进一步扩展提供了充分的理由。”

What impressed us most was the management team's disciplined approach to capacity planning and their ability to serve multiple end markets from a single, optimized manufacturing platform. We're confident this capital will unlock significant value for our investors while strengthening Michigan's position as a leader in biotechnology and advanced manufacturing.'.

最让我们印象深刻的是管理团队在产能规划方面的严谨方法，以及他们能够从一个优化的制造平台服务于多个终端市场的能力。我们相信，这笔资金将为我们的投资者释放重大价值，同时巩固密歇根州在生物技术和先进制造领域的领导地位。

About Ecovia Bio

关于Ecovia Bio

Ecovia Bio is a Michigan-based biotechnology company, a spinout from the University of Michigan, focused on the development and commercialization of sustainable, high-performance biopolymers derived from fermentation processes. The company's lead technology is based on gamma polyglutamic acid (γ-PGA), a natural biodegradable polymer with applications across multiple industries..

Ecovia Bio是一家总部位于密歇根州的生物技术公司，是从密歇根大学分拆出来的，专注于通过发酵工艺开发和商业化可持续、高性能的生物聚合物。该公司的核心技术基于γ-聚谷氨酸（γ-PGA），这是一种天然可降解聚合物，应用领域涵盖多个行业。

About Pointe Angels

关于Pointe Angels

Pointe Angels is an independent investor club in the Grosse Pointe communities, east of Detroit, Michigan. Founded in 2019, Pointe Angels provides accredited investors with opportunities for meaningful financial returns on capital investments in scalable early-stage ventures. The group is industry-agnostic and hands-on, bringing expertise in finance, operations, marketing, sales, engineering, and manufacturing to its portfolio companies..

Pointe Angels 是一个位于密歇根州底特律以东的格罗斯波因特社区的独立投资者俱乐部。成立于2019年，Pointe Angels 为经过认证的投资者提供在可扩展的早期创业项目中获得可观资本回报的机会。该团体不拘泥于特定行业，并且亲力亲为，为旗下投资组合公司提供金融、运营、营销、销售、工程和制造等领域的专业支持。

Contact:

联系人：

Media Contact

媒体联系人

Ecovia Bio: ecovia-bio.com, or contact 2489770687, 408627@email4pr.com

Ecovia Bio：ecovia-bio.com，或联系 2489770687，408627@email4pr.com

Pointe Angels: pointeangels.com, or contact micaela@pointeangels.com

天使舞鞋：pointeangels.com，或联系 micaela@pointeangels.com